Clinical pathway for the diagnosis and management of patients with COVID-19 in family practice
- Author:
Maria Victoria Concepcion P. Cruz
;
Noel L. Espallardo
;
Policarpio B. Joves Jr.
;
Anna Guia O. Limpoco
;
Jane Eflyn Lardizabal-Bunyi
;
Nenacia Ranali Nirea R. Palma-Mendoza
;
Michael Ian Sta Maria
;
Jake Cortez
;
Mark Bitong
;
Johann Montemayor
- Publication Type:Other Types
- MeSH:
COVID-19;
Family Practice
- From:
The Filipino Family Physician
2021;59(2):128-145
- CountryPhilippines
- Language:English
-
Abstract:
Background:Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, causing a pandemic. The Philippines ranks 3rd in Southeast Asia with more than 15,000 confirmed cases, and a case fatality rate of 6.01%, close to the global average of 6.33%.
Objective:This clinical pathway was developed to guide family and community physicians on the diagnosis and initial management of COVID-19 in terms of 1) clinical history and physical examination; 2) laboratory and ancillary procedures to be requested; 3) pharmacologic interventions; 4) non-pharmacologic interventions, and 5) patient outcomes to expect.
Method:The PAFP Clinical Pathways Group reviewed the published medical literature to identify, summarize, and operationalize the evidence in clinical publication on the management of patients with COVID-19 in family and community practice.
Recommendations:The recommendations are time-bound tasks on patient care processes, in terms of history and physical examination, laboratory tests, pharmacologic and non-pharmacologic interventions. The recommendations are presented as a table and algorithm.
Implementation:At the clinic level, self-audit using the recommendations of this clinical pathway as the standard may be done. At the organizational level, the PAFP should establish a new model of quality improvement initiative where self-practice audits are included as part of the program.
- Full text:PAFP-Journal_July_December-59-2-2021-pages-5-22.pdf
